Wildlife as Sentinels of Antimicrobial Resistance in Germany?
Carolina Plaza-Rodríguez1* 
Katja Alt1 
Mirjam Grobbel1 
Jens Andre Hammerl1 
Alexandra Irrgang1 Istvan Szabo1 
Kerstin Stingl1 Elisabeth Schuh1 Lars Wiehle2 Beatrice Pfefferkorn2 Steffen Naumann2 
Annemarie Kaesbohrer1 
Bernd-Alois Tenhagen1- 1Department Biological Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany
- 2Department Food, Feed, Consumer Goods, German Federal Office of Consumer Protection and Food Safety (BVL), Berlin, Germany
The presence of bacteria carrying antimicrobial resistance (AMR) genes in wildlife is an indicator that resistant bacteria of human or livestock origin are widespread in the environment. In addition, it could represent an additional challenge for human health, since wild animals could act as efficient AMR reservoirs and epidemiological links between human, livestock and natural environments. The aim of this study was to investigate the occurrence and the antibiotic resistance patterns of several bacterial species in certain wild animals in Germany, including wild boars (Sus scrofa), roe deer (Capreolus capreolus) and wild ducks (family Anatidae, subfamily Anatinae) and geese (family Anatidae, subfamily Anserinae). In the framework of the German National Zoonoses Monitoring Program, samples from hunted wild boars, roe deer and wild ducks and geese were collected nationwide in 2016, 2017, and 2019, respectively. Fecal samples were tested for the presence of Salmonella spp. (in wild boars and wild ducks and geese), Campylobacter spp. (in roe deer and wild ducks and geese), Shiga toxin-producing Escherichia (E.) coli (STEC), commensal E. coli and extended-spectrum beta-lactamase- (ESBL) or ampicillinase class C (AmpC) beta-lactamase-producing E. coli (in wild boars, roe deer and wild ducks and geese). In addition, the presence of methicillin-resistant Staphylococcus aureus (MRSA) was investigated in nasal swabs from wild boars. Isolates obtained in the accredited regional state laboratories were submitted to the National Reference Laboratories (NRLs) for confirmation, characterization and phenotypic resistance testing using broth microdilution according to CLSI. AMR was assessed according to epidemiological cut-offs provided by EUCAST. Salmonella spp. were isolated from 13 of 552 (2.4%) tested wild boar fecal samples, but absent in all 101 samples from wild ducks and geese. Nine of the 11 isolates that were submitted to the NRL Salmonella were susceptible to all tested antimicrobial substances. Campylobacter spp. were isolated from four out of 504 (0.8%) roe deer fecal samples, but not from any of the samples from wild ducks and geese. Of the two isolates received in the NRL Campylobacter, neither showed resistance to any of the substances tested. From roe deer, 40.2% of the fecal samples (144 of 358) yielded STEC compared to 6.9% (37 of 536) from wild boars. In wild ducks and geese, no STEC isolates were found. Of 150 STEC isolates received in the NRL (24 from wild boars and 126 from roe deer), only one from each animal species showed resistance. Of the 219 isolates of commensal E. coli from wild boars tested for AMR, 210 were susceptible to all 14 tested substances (95.9%). In roe deer this proportion was even higher (263 of 269, 97.8%), whereas in wild ducks and geese this proportion was lower (41 of 49, 83.7%). Nevertheless, selective isolation of ESBL-/AmpC-producing E. coli yielded 6.5% (36 of 551) positive samples from wild boars, 2.3% (13 of 573) from roe deer and 9.8% (10 of 102) from wild ducks and geese. Among the 25 confirmed ESBL-/AmpC-producing isolates from wild boars, 14 (56.0%) showed resistance up to five classes of substances. This proportion was lower in roe deer (3 of 12, 25%) and higher in wild ducks and geese (7 of 10, 70%). None of the 577 nasal swabs from wild boars yielded MRSA. Results indicate that overall, the prevalence of resistant bacteria from certain wild animals in Germany is low, which may reflect not only the low level of exposure to antimicrobials but also the low level of resistant bacteria in the areas where these animals live and feed. However, despite this low prevalence, the patterns observed in bacteria from the wild animals included in this study are an indicator for specific resistance traits in the environment, including those to highest priority substances such as 3rd generation cephalosporins, fluoroquinolones and colistin. Therefore, also continuous monitoring of the occurrence of such bacteria in wildlife by selective isolation is advisable. Furthermore, the possible role of wildlife as reservoir and disperser of resistant bacteria would need to be assessed, as wild animals, and in particular wild ducks and geese could become spreaders of resistant bacteria given their capacity for long-range movements.
Introduction
The presence of bacteria carrying antimicrobial resistance (AMR) genes is an increasingly serious and complex threat affecting public health worldwide (1). This implies that all underlying economic, social, political, environmental, and biological factors have to be considered in this context (2). Nowadays intensive contact between humans, domestic and wild animals occurs due to the expansion of urban populations and the fragmentation, encroachment and loss of natural habitats. In this scenario, it is of utmost importance to examine AMR through a “One Health” perspective (3–5). This perspective contemplates an integrated and holistic multidisciplinary approach (6), highlighting the importance of a better integration of human, livestock, wildlife and environmental aspects, in order to identify key priorities for combating AMR (2, 5, 7).
Even though wild animals are unlikely of being treated with antibiotics, the overlap between habitats inevitably increases the transmission of resistant bacteria between the different niches (8). Some wild species have been used as bioindicators or sentinels for the spread of resistant bacteria in the environment (9–11). Inadequately treated waste from humans and livestock animals treated with antimicrobial substances promotes the spread of resistant bacteria from animal stables and waste water treatment plants to the environment (12–14), and therefore to the wild fauna. However, despite the fact that many studies affirm that wild animals are reservoirs and dispersers of AMR, this role is less well-established. To make this statement, more in-depth epidemiological analyzes are needed, as the mere fact of being carriers of AMR does not mean that they can be a vehicle of contagion for humans or other animals (15, 16). In consequence, it becomes important to study the presence of AMR genes in wildlife and consider the role of wild animals in the dynamics of AMR (15), as they could represent a major epidemiological link between natural and humanized environments (15, 16). Roe deer (Capreolus capreolus) and wild boar (Sus scrofa) are the most frequent and widespread wild ungulates in Germany (17), with an estimated number of around 2.4 million individuals of roe deer and one million of wild boars, which represents 24 and 25% of the total European wild boar and roe deer population, respectively (18). As an ecologically adaptable species, both can be found in a wide variety of habitats from natural ones like forests or pastures, to more anthropogenic areas like agricultural landscapes and even urban or peri-urban areas (18, 19). Therefore, they might be prone to have contact to humans and livestock directly (20), as well as indirectly via garbage and sewage. On the other hand, some wild bird populations, including wild ducks and geese belonging to different species within the Anatidae family and the Anatinae and Anserinae subfamilies, have experienced extraordinary growth in the last decades in Germany (21, 22). Among other reasons, this is due to milder winter conditions (21). It is therefore not unusual nowadays to find large groups of wild ducks and geese in crops producing food and feed, or on wetlands and lakes used as source of drinking water for humans and livestock, or for aquatics (23, 24). Due to their capacity for long-range movements, wild birds like ducks and geese are potential spreaders of bacteria with AMR genes beyond borders (16, 25–27).
Previous studies have demonstrated the presence of AMR and resistance genes in bacteria from a large variety of wildlife species throughout Europe (28–30), including resistances to those substances of highest priority like 3rd generation cephalosporins, fluoroquinolones, colistin or even carbapenems (31, 32).
To the best of our knowledge, in Germany, the availability of studies regarding the presence of resistant bacteria in wild animals is scarce and mostly limited to certain regions (33–35). This makes that the role of wild animals in the dynamics of AMR in Germany is still not fully understood. Based on previous studies it is clear that the presence of distinct bacterial species, their antimicrobial susceptibility, as well as their profiles of resistance genes might be highly variable among different countries (19). Therefore, the aim of the present study was to investigate the occurrence and the antibiotic resistance patterns of Salmonella spp., Campylobacter spp., Shiga toxin-producing Escherichia (E.) coli (STEC), methicillin-resistant Staphylococcus aureus (MRSA), commensal E. coli, and extended-spectrum beta-lactamase- (ESBL) or ampicillin class C (AmpC) beta-lactamase-producing E. coli in samples collected from wild boars, roe deer and wild ducks and geese in Germany within the National Zoonoses Monitoring Program.
Materials and Methods
In the framework of the German National Zoonoses Monitoring Program, 942 samples from hunted wild boars, 573 from roe deer and 100 from wild ducks and geese were collected nationwide in 2016, 2017, and 2019, respectively. Samples from wild ducks and geese mainly originated from cadavers collected for the monitoring of avian influenza, or taken from hunted birds. Fecal samples were tested for the presence of Salmonella spp. (in wild boars and wild ducks and geese), Campylobacter spp. (in roe deer and wild ducks and geese), STEC, commensal E. coli, and ESBL-/AmpC-producing E. coli (in wild boars, roe deer and wild ducks and geese) (Table 1). In addition, the presence of MRSA was investigated in nasal swabs from wild boars. No sample size was specified for each federal state, as the investigations took place depending on the availability of suitable samples. Samples were provided from all federal states except Hamburg and Bremen.
Table 1. Overview of prevalence and resistance studies carried out for wildlife in the German Zoonoses-Monitoring in 2016, 2017, and 2019.
Primary isolation was carried out by the accredited regional state laboratories using harmonized procedures (Table 2). Results of the analysis of samples were reported to the Federal Office of Consumer Protection and Food Safety (BVL) for aggregation and reporting at national level. Isolates obtained were submitted to the National Reference Laboratories (NRLs) at the German Federal Institute for Risk Assessment (BfR) for confirmation, characterization and phenotypic resistance testing.
Table 2. Microbiological methods used in the investigation according to microorganism and survey year.
Isolates from Salmonella spp., Campylobacter spp., STEC, E. coli, and MRSA were confirmed and characterized using the designated, internationally recognized procedures (Table 2). For the determination of resistance, broth microdilution method according to CLSI M07-A10 and CLSI M45-A was used (42, 43).
The isolates were subjected to the examination spectrum of antimicrobial substances established at BfR. For this purpose, the ready-made plate formats EUVSEC and EUVSEC2 (Salmonella spp. and E. coli), EUCAMP2 (Campylobacter spp.), and EUST (MRSA) from the company TREK Diagnostic Systems were used (44).
AMR was assessed according to epidemiological cut-offs provided by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and fixed in Commission Implementing Decision 2013/652/EC (45). Technical specifications proposed by EFSA (40) were applied for MRSA.When no epidemiological cut-off values were described, the evaluation was carried out based on EFSA criteria (41). Isolates from the wild-type population in this publication are further called susceptible to the respective agent, those with MIC values above the cut-off resistant. An overview of the antimicrobial substances used, the tested concentration ranges as well as the evaluation criteria can be found in Supplementary Tables 1–3.
Prevalence of the zoonotic pathogens in the fecal samples from wild animals as well as the prevalence of resistant bacteria within the isolates were calculated as the proportion of positive samples resp. resistant isolates and with the associated 95% confidence interval shown. The 95% confidence interval was calculated according to the procedure determined by Agresti and Coull (46).
Escherichia coli isolates resistant to third generation cephalosporins were further characterized in regard of the harbored ESBL/pAmpC genes. Therefore, isolates were pre-screened by real-time PCR for the presence of the typical betalactamases TEM, CTX, SHV, and CMY (47). ESBL variant was then determined by Sanger sequencing of PCR products. TEM variant was only determined in case no other ESBL/pAmpC gene was detected, as most E. coli harbor the narrow spectrum beta-lactamase blaTEM−1. Isolates which were negative in real-time PCR were additionally screened for the presence of blaFOX, blaMOX, blaCIT, blaDHA, and blaEBC by PCR. As some betalactamase variants differ within the primer regions, we could not distinguish between CTX-M-14 and −17 (CTX-M-14 like), between CTX-M-65 and 90 (CTX-M-65-like), and between CMY-2/-22 and -66 (CMY-2-like).
Results
Salmonella spp.
Salmonella spp. were isolated from 13 of 552 (2.4%) wild boar fecal samples (Table 3).
Table 3. Overview of the examined samples and the prevalence and 95% confidence interval (95% CI) of different microorganisms in feces samples (Salmonella spp., Campylobacter spp., STEC, commensal E. coli, and ESBL-/AmpC-producing E. coli) and nasal swabs (MRSA) from wild boar, roe deer and wild ducks and geese in 2016, 2017 and 2019, respectively.
Of the 13 isolates found in fecal samples from wild boars, 11 were submitted to the BfR. Serotyping of these isolates resulted in three Salmonella Enteritidis, one Salmonella Typhimurium, one Salmonella Stanleyville, and six Salmonella enterica subspecies I., that could not be further identified by serotyping.
Of the 11 isolates, nine (81.8%) were susceptible to all tested substances (Table 4). Just two isolates (18.2%) showed resistance to two or three groups of active ingredients (Figure 1), including fluoroquinolones and colistin (Table 5).
Table 4. Overview of the isolates for which a resistance test was carried out and prevalence and 95% confidence interval (95% CI) of resistant isolates.
Figure 1. Overview of the isolates found in wild boar, roe deer (excluding Campylobacter spp.) and wild ducks and geese, including information on the percentage of samples that were susceptible to al testes substances or resistant to one (1x res.), two (2x res.), three (3x res.), four (4x res.) or more than four classes (> 4x res.) of antibiotic substances.
Table 5. Number and proportion of tested resistant isolates from wild boars and the number of substance classes to which the isolates were resistant.
Salmonella spp. were not found in any of the 101 samples from wild ducks and geese (Table 3).
Campylobacter spp.
Campylobacter spp. were isolated from four out of 504 (0.8%) fecal samples from hunted roe deer (Table 3). Three isolates were sent to the BfR, but one of them could not be re-cultivated. Of the two remaining isolates (both Campylobacter jejuni), neither showed resistance to any of the six substances tested (Table 4).
Campylobacter spp. were absent in the 93 fecal samples from wild ducks and geese (Table 3).
STEC
Out of 536 fecal samples tested from wild boars, 37 yielded STEC (6.9%) (Table 3). In total, 24 STEC isolates were sent to the BfR for further typing and resistance testing. The results of the STEC typing from wild boars are available in Supplementary Table 4. From those isolates, three did not produce measurable Shiga toxin. With the exception of one isolate, all isolates had a stx2 gene; meanwhile just five isolates carried a stx1 gene. One isolate could not be typed with regard to its O antigen, but was serologically rough. The rest of the isolates belonged to 14 different O groups, including the O157 group. The two isolates belonging to this group had both also the H7 antigen and the genes eae and ehxA, which code for virulence factors. The eae gene was also detected in isolates from serogroups O26 and O45. These isolates also carried the ehxA gene. The eae gene was not found in any other serogroup. The ehxA gene was detected in 15 isolates (62.5%).
From the 24 STEC isolates from wild boars tested for resistance, all were completely susceptible except one (95.8%). This isolate showed resistance to six substance classes (Figure 1), including the (fluoro-)quinolone nalidixic acid and ciprofloxacin (Table 5).
From roe deer, 40.2% (144 of 358) of the fecal samples yielded STEC. One hundred twenty-six STEC isolates from the feces of hunted deer were submitted to the BfR. The results of the STEC typing from roe deer are available in Supplementary Table 5. Twenty-five of these 126 isolates did not produce measurable Shiga toxin with the ELISA system used. Most of the isolates had a stx2 gene (n = 92) and 40 isolates carried a stx1 gene. One hundred fifteen isolates belonged to 19 different O serogroups, and 11 could not be typed. Of the serogroups, O146 was most frequently represented, meanwhile the serogroup O157 was not detected in any of the analyzed isolates. The eae gene occurred in one isolate of the serogroup O26. This isolate also carried the ehxA gene. The ehxA gene was detected in 54 isolates.
Of the 126 STEC isolates tested for resistance, only one (0.8%) showed resistance to gentamicin. As shown in Figure 1 and Table 6, all the other isolates were without exception susceptible to all tested substances.
Table 6. Number and proportion of tested resistant isolates from roe deer and the number of substance classes to which the isolates were resistant.
In wild ducks and geese, no STEC isolates were found.
Commensal E. coli
Commensal E. coli were isolated from 95% (511 of 538) of the fecal samples from wild boars. Of the 219 isolates of E. coli from wild boars tested for AMR, 210 (95.9%) were susceptible to all 14 tested substances (Table 4). Among the nine other isolates, seven showed resistance only to one substance class. The other two isolates showed resistance to two or four classes (Figure 1). No resistance to 3rd generation cephalosporins or carbapenems was found, but some isolates were resistant to ciprofloxacin and nalidixic acid (0.9% each) and four isolates (1.8%) showed resistance to colistin (Table 5).
A total of 93.7% (537 of 573) of the fecal samples from hunted roe deer yielded commensal E. coli. Among the 269 isolates, 263 (97.8%) were susceptible to all tested substances, while six (2.2%) displayed resistance to at least one of the tested antimicrobials (Table 4). Four of these isolates were resistant to only one substance class and two isolates were resistant to three, resp. five substance classes (Figure 1). Resistance to the 3rd generation cephalosporins (cefotaxime and ceftazidime) and to the fluoroquinolone ciprofloxacin were observed (0.4% of the isolates each) (Table 6). No colistin or meropenem resistant E. coli were observed in isolates from roe deer.
In wild ducks and geese, 50% (51 of 102) of the fecal samples yielded commensal E. coli. Of the 49 isolates submitted to the BfR, 41 (83.7%) were sensitive to all tested substances (Table 7). Only two isolates (4.1%) were resistant to two resp. three substance classes (Figure 1). Among the resistant isolates, resistance to 3rd generation cephalosporins, fluoroquinolones and colistin was observed in 2% of the isolates each (Table 7).
Table 7. Number and proportion of tested resistant isolates from wild ducks and geese and the number of substance classes to which the isolates were resistant.
ESBL-/AmpC-Producing E. coli
Selective isolation yielded isolates suspicious of being ESBL-/AmpC-producing E. coli in 6.5% (36 of 551) of the samples from wild boars (Table 3). Of the 25 isolates confirmed at the BfR, 23 showed an ESBL and two an AmpC phenotype. Among these isolates, that were resistant to cefotaxime, ceftazidime and ampicillin, 11 (44%) showed no other resistance, while 14 (56%) showed resistance to up to five further substance classes (Figure 1 and Table 5). Apart from colistin, tigecycline and meropenem, resistance was observed to all other substances in at least one isolate. Nine isolates (36%) were resistant to tetracycline and eight isolates (32%) to ciprofloxacin. Wild boars showed the highest diversity of resistance determinants among the three groups (Figure 2). The most prevalent ESBL gene was blaCTX−M−1 (56%), followed by blaCTX−M−15 (20%) and blaCTX−M−14-like (12%). One of the isolates with an AmpC phenotype harbored a blaCMY−2 like gene, whereas the other one did not harbor one of the genes screened for.
Figure 2. Resistance determinants of E. coli isolates obtained from the selective ESBL/AmpC monitoring of wild boars, roe deer, and wild ducks and geese.
ESBL-/AmpC-producing E. coli were detected in 13 of the 573 (2.3%) fecal samples from hunted roe deer (Table 3). Of the twelve isolates submitted to the BfR, phenotypically three showed an AmpC and nine and ESBL phenotype. Nine of those twelve isolates (75%) showed only resistance to cefotaxime, ceftazidime and ampicillin. Three isolates (25%) showed additional resistances to trimethoprim, sulfamethoxazole, gentamicin, ciprofloxacin or tetracycline (Figure 1 and Table 6). No resistance was observed to chloramphenicol, colistin, meropenem and tigecycline. There was a similar distribution of isolates harboring the ESBL genes blaCTX−M−1 (33%) and bla CTX−M−15 (25%) and AmpC-producing isolates (25%). As none of the most prevalent pAmpC genes could be detected, an overexpression of chromosomal AmpC was assumed but not further characterized. The remaining two isolates harbored the blaCTX−M−14 gene.
In samples from wild ducks and geese, ESBL-/AmpC-producing E. coli were isolated from ten of the 102 (9.8%) fecal samples (Table 3). Of the ten isolates submitted to the BfR, eight showed an ESBL phenotype, one an AmpC phenotype, while another one exhibited ESBL and AmpC phenotype. Among the ten confirmed ESBL-/AmpC-producing E. coli isolates submitted to the BfR with resistance to cefotaxime, ceftazidime and ampicillin, seven (70%) showed additional resistance up to five classes of substances, including nalidixic acid and ciprofloxacin (in 50% of isolates each). Resistance to colistin or meropenem was not observed (Table 7). The most prevalent ESBL was again CTX-M-1 (60%). CTX-M-15 was produced by 30% of the isolates, including the one which showed an ESBL and AmpC phenotype and produced an additional DHA betalactamase. The isolate with the AmpC phenotype alone only harbored a blaTEM−1, indicating an additional resistance mechanism which wasn't detected so far.
MRSA
From the 577 nasal swab samples from wild boars tested, five isolates were found suspicious of being MRSA. However, none of them could be confirmed as MRSA at the BfR (Table 3).
Discussion
The examination of the fecal samples from wild animals included in this study revealed low levels of the important zoonotic pathogens Salmonella spp., Campylobacter spp., and MRSA. In contrast, STEC were frequently found in roe deer (40.2%), but infrequently in wild boars and were absent in wild ducks and geese. The antibiotic resistance patterns found in this study indicate that overall, the prevalence of AMR is low in bacteria from the studied wild animals in Germany. This might reflect not only the low level of exposure of these wildlife species to antimicrobials but also the low level of resistant bacteria in the areas where these animals live and feed (16). These good results could be also interpreted as an indication of the low level of anthropogenic impact in these areas, or of an adequate management of antibiotic residues of human or livestock origin in Germany. However, this interpretation should be done with caution, since this study has also shown that wild boars, roe deer and wild ducks and geese are carriers of bacteria with specific resistance traits including colistin, fluoroquinolones or 3rd generation cephalosporins. These substances are considered highest priority critically important antimicrobials by the World Health Organization (48). The origin of these isolates is not known, but due to the lifestyle of the wild animals tested, uptake of the resistant bacteria via feed or drinking water, or through direct contact with garbage and sewages, is a likely reason for carriage (49). Other factors than geographic distance to humans, livestock or wastes should be considered in future studies (50), as it has been demonstrated that wildlife populations living in remote places with little direct human or livestock contact can also harbor resistant bacteria (51). The possible role of wildlife as reservoir and disperser of resistant bacteria in Germany would need to be further assessed by including adequate epidemiological analysis, as wild animals, and in particular, wild ducks and geese could become spreaders of resistant bacteria given their capacity for long-range movements. Samples included in this study were distributed across the federal states of Germany. Two federal states did not participate in sampling. Both are city-states with only small hunting areas. One federal state took several times the required number of samples in wild boars and in roe deer. The impact of these additional samples on the overall prevalence estimates was considered minimal for the pathogens studied, as the prevalences recorded in this federal state were similar to those obtained without the inclusion of its samples (data not shown). The total number of samples from wild ducks and geese was low. Therefore, the obtained results should be interpreted with caution, and future studies including a higher number of samples, should be carried out to verify that the results obtained in this study can be extrapolated to the general population of wild ducks and geese in Germany.
As available studies have shown that the prevalence of bacteria and the results of the antimicrobial sensitivity analysis could be highly variable among different geographical locations (19), further analyses with respect to regional distribution and genetic traits need to be carried out to examine potential regional hot spots of AMR in wildlife in Germany.
Our results showed that even when Salmonella spp. were found in fecal samples from wild boars hunted in Germany, the prevalence is low. This is in accordance with previous reports from Spain, Portugal and Italy that likewise found low prevalence of Salmonella isolates from wild boar feces (52–55). However, substantially higher Salmonella prevalences have been be found in serum samples, tonsils or lymph nodes (31, 54, 55), or in animals co-habiting with livestock (56). Salmonella Enteritidis was the most frequent serotype, which agrees with previous investigations, which also detected Salmonella Enteritidis in wild boars (57). However, serovar Salmonella Choleraesuis that has been found increasingly in recent years in diseased wild boars in Germany (34, 35) was not detected in our study. A greater diversity of serotypes was recognized in Spain by Navarro-Gonzalez et al. (56) and Gil Molino et al. (55).
As Navarro-Gonzalez et al. (56), we found low resistance rates in the Salmonella isolates submitted for testing, with the vast majority of the isolates from wild boars being sensitive to all substances. This differs from previous studies that found higher resistance patterns with almost all isolates resistant to at least one antimicrobial substance (31, 35, 55). Despite the high proportion of fully susceptible isolates found in our study, resistance to ciprofloxacin and colistin were found in one Salmonella Enteritidis isolate each in agreement with previous studies (31).
The absence of Salmonella spp. in wild ducks and geese is in agreement with previous studies, where predominantly negative results or very low prevalence of Salmonella spp. in wild birds has been observed (27, 58–61). Therefore, as other authors hypothesized, the importance of wild birds in spreading Salmonella could be limited to those residing in areas that are highly contaminated by human waste or domestic animal manure (60, 61).
In our study, Campylobacter spp. were rarely found in roe deer feces. This is consistent with previous studies that suggest that wild cervids, and in particular roe deer, are of limited importance as Campylobacter reservoirs (28, 62–64). Although several authors have isolated Campylobacter spp. from wild deer, the number of studies that include their resistance profiles is still very limited. Carbonero et al. (65) reported more than 60% of the isolates from roe deer resistant to at least one antimicrobial substance, including streptomycin, tetracycline and ciprofloxacin. In our study, the two Campylobacter jejuni submitted to the BfR were susceptible to all tested substances.
Despite the fact that the intestinal tract of wild birds is considered a favorable environment for Campylobacter colonization, with reported prevalence ranging from 9.2 to 52.2% in wild ducks and geese (66, 67), Campylobacter spp. were absent in fecal samples from wild ducks and geese analyzed in this study. This absence could be due to loss of Campylobacter survival due to extreme temperatures, low water content, or ultra-violet light levels to which fecal content of bird cadavers sampled in this study were subjected.
Prevalence of STEC reported in wildlife in Europe shows a general pattern with a lower prevalence in wild boars (4.8–9%) than in deer (25–42%) (68–72). This is in line with our results. The isolates from wild boars and roe deer submitted to the BfR showed considerable diversity. The most prevalent Shiga toxin gene was stx2, whereas stx1 was detected only in 40 isolates from roe deer and 5 from wild boars. This is also in concordance with previous studies carried out in Europe, which reported higher prevalence of stx2 than of stx1 among STEC isolates from wild ungulates (64, 69, 70, 72, 73). Our data reinforce the role of certain wild species as reservoirs of STEC strains that are potentially pathogenic to humans, as two isolates found in wild boars were described as E. coli O157:H7 (0.37%). Although there are studies in which this STEC serotype was absent in wild ungulates (28), in other studies prevalences of 0.75–3.41% are described (74, 75). Other clinical relevant serotypes (e.g., O103:H2 and O26:H11) with high similarity to human strains are also described in game meat in Germany (76). The serotype O27:H30, that has been associated with deer previously (71, 77), was found in three isolates from roe deer. Of the 150 STEC isolates analyzed at the BfR only one from each animal species showed resistance. The resistant isolate from wild boars showed resistance to six substance classes, including the (fluoro-)quinolones nalidixic acid and ciprofloxacin. This high percentage of isolates susceptible to the antimicrobial substances observed among STEC strains from wild animals has also been found in previous studies (71, 74).
Despite the fact that some studies suggest that wild birds could act as carriers of STEC, in general zero or low levels of STEC have been described in wild birds (62, 78, 79). This is in line with our findings.
As part of the physiological gut microbiota, commensal E. coli have been reported in wild mammals with high prevalence (52, 80, 81). Likewise, E. coli were found in our study in almost all the analyzed samples from wild boars and roe deer, but only in 50% (51 of 102) of the samples from wild ducks and geese. This observation is in the range described by previous studies that revealed a large variation in the prevalence of E. coli in geese, ranging from below 10–100% (59, 70, 82).
Resistance of commensal E. coli from wild animal fecal samples analyzed in this study were typically low. This is in agreement with the available literature, which shows in general low antimicrobial resistance rates among E. coli from wild ungulates (28, 80, 83–85) or wild birds (86), compared to livestock animals. To some concern, some isolates from the animal species included in this study exhibited resistance to 3rd generation cephalosporins (cefotaxime and ceftazidime), fluoroquinolones or colistin (in 1.8 and 2% of the isolates in wild boar and wild ducks and geese, respectively). Resistance to fluoroquinolones in wild ungulates has been previously described (81). Colistin resistance genes have been previously found in E. coli isolates from wild birds (87, 88), but to the best of our knowledge, this is the first report of colistin resistance in E. coli isolates from wild boars.
Our results showed that in Germany wild boars, roe deer and wild ducks and geese are reservoirs of ESBL-/AmpC-producing E. coli, which may reflect the general distribution of such bacteria in the environment outside of farm animal husbandry. Indeed, the proportion of positive samples found in wild boars corresponded roughly to the detection rate that was observed in a cross-sectional study in humans in Germany (89). The presence of ESBL-/AmpC-producing E. coli in wild animals is in line with previous studies on wild birds (33, 90–93) and wild ungulates (80, 84, 94, 95), which reported prevalences similar to those reported in our study.
Phenotypically grouped in ESBL-producers, AmpC-producers or ESBL+AmpC-producers, the ESBL-producing isolates dominated in all animal species included in this study, which might be linked with contact to human or livestock waste. The proportion of the AmpC- phenotype was higher in the isolates from roe deer (25%). High proportions and modest genetic diversity of ESBLs producing E. coli from wild animals have been previously reported (33, 91–93, 96).
Genotypically, CTX-M-1 was the most prevalent ESBL (51%), but in 36% of the isolates harbored a CTX-M-15 or CTX-M-9-group betalactamase. In livestock, CTX-M-1 is the most prevalent ESBL, especially in pigs and cattle, whereas CTX-M-15 and CTX-M-14 are detected only in minor proportions in livestock or meat (97, 98). One the other hand, in humans CTX-M-15 is predominant from clinical ESBL associated infection (99). Nevertheless, in non-clinical settings, CTX-M-1 is also found as the most prevalent ESBL variant (100). Therefore, a clear transmission route can not be derived from these data. Conceivable transmission could be manure fertilized fields, contaminated water sources or waste. Although SHV and CMY-2 is frequently detected in poultry production (101), none of these betalactamases were detected in ducks and geese and only one CMY-2-like isolate was found in wild boars. This might hint to hardly transmission from poultry production into the wild.
Among the confirmed ESBL-/AmpC-producing E. coli isolates from wild animals with characteristic resistance to betalactams, a significant percentage presented further resistance to up to five classes of substances, including fluoroquinolones. This percentage was numerically higher in wild ducks and geese, followed by wild boars and finally roe deer. In contrast to the non-selectively isolated commensal E. coli, resistance to colistin was not observed in ESBL-/AmpC-producing E. coli.
MRSA has been previously found in meat from wild boars in Germany (102). However, in our study it was noticeable that all isolates from wild boars sent to the BfR with suspicion of MRSA were not confirmed as MRSA, but instead turned out to be methicillin-susceptible Staphylococcus aureus. It could be assumed that the S. aureus, incorrectly identified as MRSA, were able to survive in the selective media because of other resistance mechanisms, such as increased beta-lactamase activity (103). The absence of MRSA in wild boars is in line with previous studies where MRSA were absent or rarely found in nasal swabs taken from wild boars (104–109).
Despite the low levels of resistance found in the animal species studied, our results underline that antimicrobial resistance is less frequent in roe deer, followed by wild boars and finally wild ducks and geese. This can be clearly seen in the resistance profiles of commensal E. coli and ESBL-/AmpC-producing E. coli (Figure 1), where data is available for all three studied animal species. This is in line with available data that suggest that carnivorous and omnivorous species are generally at a higher risk of AMR carriage (16). Particularly low resistance rates have been found in isolates from roe deer, which could demonstrate a lower level of exposure of roe deer to human and animal waste. Wild boars have been reported to carry resistant bacteria to a greater extent than other wild animal species, as in addition to their omnivorous behavior, their increased mobility and their high tolerance to human disturbance (19, 30), brings them to a closer contact with humans and livestock. On the other hand, the higher resistance found in wild ducks and geese might be attributable to a greater contact with wastewater or domestic animal manure containing high levels of bacteria carrying antibiotic resistance. However, we have to take into account that the low number of samples from wild ducks and geese analyzed in this study makes our margin of error larger, as shown by the wide confidence interval, so the actual prevalence of the population may vary. Future studies focusing simultaneously on several animal species living in the same habitat are needed to confirm the observed differences and determine the influencing factors.
One of the major concerns regarding the presence of resistant bacteria in wild animals is the potential contamination of meat with resistant bacteria during game meat production (110). Injuries to the digestive tract caused by gunshots, lower degree of bleeding compared to slaughtered animals and delayed evisceration of game bodies under suboptimal environmental conditions (111, 112), are the main factors that could contribute to such contamination. Since consumer exposure to resistant bacteria is possible through the consumption of contaminated meat (113), careful hygiene practices must be observed during harvesting, processing and marketing of game meat. Special attention should be paid to the presence of bacteria resistant to 3rd generation cephalosporins, fluoroquinolones, colistin or even carbapenems, which pose a serious public health concern. Further studies evaluating the relationship between the prevalence of resistance in feces from wild animals and the presence of resistant bacteria in game meat is needed in Germany in order to evaluate this potential pathway for human exposure to resistant bacteria.
The population size of the wild animals contemplated in this study has been increasing during the last decades in most of the European countries (18). This fact together with the increased fragmentation of natural ecosystems, has led to a greater proximity of these animal species to urban and peri-urban areas. Therefore, it may be advisable to investigate continuously the occurrence of resistant bacteria in wildlife. Additionally, as humans, livestock and environment play a relevant role in the origin of AMR in wild animals, a “One Health” approach would be essential when approaching it (114). Through this approach, efforts should focus on the determination of the role of wildlife in the dynamics of AMR, especially for those resistance traits to high priority substances for human and animal health. As the interpretation of resistance patterns also depends on the sampling techniques, the methodology and laboratory techniques employed to determine the susceptibility to antibiotics, standardization and harmonization need further improvement (19, 115) to allow for the comparison of data on AMR in wildlife between countries. Detailed regional studies will be required to identify factors affecting AMR in wild animals as well as potential pathways from which wildlife is acquiring resistant bacteria. In addition, the identification and evaluation of strategies to reduce the spread of AMR from humans and livestock to the environment and wildlife will be essential (116).
Conclusions
Wild boars, roe deer and wild ducks and geese can be used as bioindicators or sentinels for the presence of resistant bacteria in the environment. Our results indicate that overall, the prevalence of resistant bacteria in the selected wild animals in Germany is low, which may reflect the low level of exposure of these animals to antimicrobials and the low level of resistant bacteria in the environment. However, the patterns observed in bacteria from the wild animals included in this study are an indicator for specific resistance traits in the environment, including those to highest priority substances such as 3rd generation cephalosporins, fluoroquinolones and colistin. To account for the low prevalence of AMR in wildlife in conjunction with the presence of resistance to critically important antimicrobials use of selective isolation in the continuous monitoring of the AMR in wildlife is advisable. Furthermore, the possible role of wildlife as reservoir of resistant bacteria would need to be assessed, as wild animals, and in particular wild ducks and geese could become spreaders of resistant bacteria given their capacity for long-range movements.
Data Availability Statement
The data analyzed in this study is subject to the following licenses/restrictions: The dataset used in this article belongs to the German National Zoonoses Monitoring Program. Currently these data are not publicly available, however work is currently underway to create a public database that contains this data along with many other data from other programs and years. Requests to access these datasets should be directed to Carolina Plaza-Rodríguez, Carolina.Plaza-Rodriguez@bfr.bund.de.
Author Contributions
Conceptualization: CP-R and B-AT. Formal analysis: CP-R, B-AT, and KA. Original draft preparation: CP-R. Review and editing: CP-R, KA, MG, JAH, AI, IS, KS, ES, LW, BP, SN, AK, and B-AT. All authors contributed to the article and approved the submitted version.
Funding
This study was carried out with internal funding from the German Federal Institute for Risk Assessment (43-001 and 43-002).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We wish to thank regional laboratories of the federal states of Germany and the personnel and hunters who contributed to the collection and initial analysis of the fecal samples from the wild animals. We furthermore gratefully acknowledge the excellent work of the technical staff of the laboratories at BfR in particular Silke Jahn and Tanja Skladnikiewicz-Ziemer. We wish also to thank Dr. Victoria Plaza for her support during the literature review.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fvets.2020.627821/full#supplementary-material
References
1. WHO(2014). Antimicrobial Resistance: Global Report on Surveillance. Jeneva: World Health Organization.
2. Lammie SL, Hughes JM. Antimicrobial resistance, food safety, and one health: the need for convergence. Annu. Rev. Food Sci. Technol. (2016) 7:287–312. doi: 10.1146/annurev-food-041715-033251
3. Loh EH, Zambrana-Torrelio C, Olival KJ, Bogich TL, Johnson CK, Mazet JAK, et al. Targeting transmission pathways for emerging zoonotic disease surveillance and control. Vector Borne Zoonotic Dis. (2015) 15:432–7. doi: 10.1089/vbz.2013.1563
4. Dolejska M, Literak I. Wildlife is overlooked in the epidemiology of medically important antibiotic-resistant bacteria. Antimicrob. Agents Chemother. (2019) 63:e01167–19. doi: 10.1128/AAC.01167-19
5. White A, Hughes JM. Critical importance of a one health approach to antimicrobial resistance. EcoHealth. (2019) 16:404–9. doi: 10.1007/s10393-019-01415-5
6. Zinsstag J, Schelling E, Waltner-Toews D, Tanner M. From “one medicine” to “one health” and systemic approaches to health and well-being. Prev. Vet. Med. (2011) 101:148–56. doi: 10.1016/j.prevetmed.2010.07.003
7. Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. (2014) 12:465–78. doi: 10.1038/nrmicro3270
8. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. (2008) 451:990–3. doi: 10.1038/nature06536
9. Radhouani H, Poeta P, Gonçalves A, Pacheco R, Sargo R, Igrejas G. Wild birds as biological indicators of environmental pollution: antimicrobial resistance patterns of Escherichia coli and enterococci isolated from common buzzards (Buteo buteo). J. Med. Microbiol. (2012) 61:837–43. doi: 10.1099/jmm.0.038364-0
10. Smith S, Wang J, Fanning S, McMahon BJ. Antimicrobial resistant bacteria in wild mammals and birds: a coincidence or cause for concern? Ir. Vet. J. (2014) 67:8. doi: 10.1186/2046-0481-67-8
11. Furness LE, Campbell A, Zhang L, Gaze WH, McDonald RA. Wild small mammals as sentinels for the environmental transmission of antimicrobial resistance. Environ. Res. (2017) 154:28–34. doi: 10.1016/j.envres.2016.12.014
12. Friese A, Schulz J, Hoehle L, Fetsch A, Tenhagen BA, Hartung J, et al. Occurrence of MRSA in air and housing environment of pig barns. Vet. Microbiol. (2012) 158:129–35. doi: 10.1016/j.vetmic.2012.01.019
13. UBA(2018). Antibiotics and Antibiotic Resistances in the Environment. Background, Challenges and Options for Action. Available online at: https://www.umweltbundesamt.de/sites/default/files/medien/479/publikationen/181101_uba_hg_antibiotika_engl_bf_low.pdf. (accessed January 12, 2021).
14. Hendriksen RS, Munk P, Njage P, van Bunnik B, McNally L, Lukjancenko O, et al. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Nat. Commun. (2019) 10:1124. doi: 10.1038/s41467-019-08853-3
15. Arnold KE, Williams NJ, Bennett M. Disperse abroad in the land: the role of wildlife in the dissemination of antimicrobial resistance. Biol. Lett. (2016) 12:20160137. doi: 10.1098/rsbl.2016.0137
16. Vittecoq M, Godreuil S, Prugnolle F, Durand P, Brazier L, Renaud N, et al. Antimicrobial resistance in wildlife. J. Appl. Ecol. (2016) 53:519–29. doi: 10.1111/1365-2664.12596
17. Jagdverband (2020). Deutscher-Jagdverband. Available online at: https://www.jagdverband.de/. (accessed January 12, 2021).
18. Deinet S, Ieronymidou C, McRae L, Burfield IJ, Foppen RP, Collen B, et al. Wildlife Comeback in Europe: The Recovery of Selected Mammal and Bird Species London: ZSL (2013).
19. Torres RT, Fernandes J, Carvalho J, Cunha MV, Caetano T, Mendo S, et al. Wild boar as a reservoir of antimicrobial resistance. Sci. Total. Environ. (2019) 717:135001. doi: 10.1016/j.scitotenv.2019.135001
20. Kukielka E, Barasona JA, Cowie CE, Drewe JA, Gortazar C, Cotarelo I, et al. Spatial and temporal interactions between livestock and wildlife in South Central Spain assessed by camera traps. Prev. Vet. Med. (2013) 112:213–21. doi: 10.1016/j.prevetmed.2013.08.008
21. Flade MC, Grüneberg C, Sudfeldt C, Wahl J. Birds and Biodiversity in Germany 2010 Target. Münster: DDA, NABU, DRV, DO-G (2008).
22. Fox AD, Ebbinge BS, Mitchell C, Heinicke T, Aarvak T, Colhoun K, et al. Current estimates of goose population sizes in western Europe, a gap analysis and assessment of trends. Ornis Svec. (2010) 20:115–27. doi: 10.34080/os.v20.19922
23. Meerburg BG, Koene MG, Kleijn D. Escherichia coli concentrations in feces of geese, coots, and gulls residing on recreational water in The Netherlands. Vector Borne Zoonotic Dis. (2011) 11:601–3. doi: 10.1089/vbz.2010.0218
24. Gorham TJ, Lee J. Pathogen loading from Canada geese faeces in freshwater: potential risks to human health through recreational water exposure. Zoonoses Public Health. (2016) 63:177–90. doi: 10.1111/zph.12227
25. Tsiodras S, Kelesidis T, Kelesidis I, Bauchinger U, Falagas ME. Human infections associated with wild birds. J. Infect. (2008) 56:83–98. doi: 10.1016/j.jinf.2007.11.001
26. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J. Call of the wild: antibiotic resistance genes in natural environments. Nat. Rev. Microbiol. (2010) 8:251–9. doi: 10.1038/nrmicro2312
27. Elmberg J, Berg C, Lerner H, Waldenström J, Hessel R. Potential disease transmission from wild geese and swans to livestock, poultry and humans: a review of the scientific literature from a one health perspective. Infect. Ecol. Epidemiol. (2017) 7:1300450. doi: 10.1080/20008686.2017.1300450
28. Lillehaug A, Bergsjø B, Schau J, Bruheim T, Vikøren T, Handeland K. Campylobacter spp., Salmonella spp., Verocytotoxic Escherichia coli, and antibiotic resistance in indicator organisms in wild cervids. Acta Vet. Scand. (2005) 46:23. doi: 10.1186/1751-0147-46-23
29. Sousa M, Gonçalves A, Silva N, Serra R, Alcaide E, Zorrilla I, et al. Acquired antibiotic resistance among wild animals: the case of Iberian Lynx (Lynx pardinus). Vet. Q. (2014) 34:105–12. doi: 10.1080/01652176.2014.949391
30. Torres RT, Cunha MV, Caetano T, Mendo S, Serrano E, Fonseca C. Antimicrobial resistance in wild boar in Europe: present knowledge and future challenges. In: Meijaard E, Melletti M, editors Ecology, Conservation and Management of Wild Pigs and Peccaries. Cambridge: Cambridge University Press (2017). p. 437–44. doi: 10.1017/9781316941232.040
31. Zottola T, Montagnaro S, Magnapera C, Sasso S, De Martino L, Bragagnolo A, et al. Prevalence and antimicrobial susceptibility of Salmonella in European wild boar (Sus scrofa); Latium Region – Italy. Comp. Immunol. Microbiol. Infect. Dis. (2013) 36:161–8. doi: 10.1016/j.cimid.2012.11.004
32. Bonardi S, Pitino R. Carbapenemase-producing bacteria in food-producing animals, wildlife and environment: a challenge for human health. Ital. J. Food Saf. (2019) 8:7956. doi: 10.4081/ijfs.2019.7956
33. Guenther S, Grobbel M, Beutlich J, Bethe A, Friedrich ND, Goedecke A, et al. CTX-M-15-type extended-spectrum beta-lactamases-producing Escherichia coli from wild birds in Germany. Environ. Microbiol. Rep. (2010) 2:641–5. doi: 10.1111/j.1758-2229.2010.00148.x
34. Methner U, Heller M, Bocklisch H. Salmonella enterica subspecies enterica serovar Choleraesuis in a wild boar population in Germany. Eur. J. Wildlife Res. (2010) 56:493–502. doi: 10.1007/s10344-009-0339-3
35. Methner U, Merbach S, Peters M. Salmonella enterica subspecies enterica serovar Choleraesuis in a German wild boar population: occurrence and characterisation. AVS. (2018) 60:65. doi: 10.1186/s13028-018-0422-4
36. Grimont P, Weill FX. Antigenic Formulae of the Salmonella Serovars. WHO Collaborating Centre for Reference and Research on Salmonella. 9th ed. Paris: Institut Pasteur (2007).
37. Tzschoppe M, Martin A, Beutin L. A rapid procedure for the detection and isolation of enterohaemorrhagic Escherichia coli (EHEC) serogroup O26, O103, O111, O118, O121, O145 and O157 strains and the aggregative EHEC O104:H4 strain from ready-to-eat vegetables. Int. J. Food Microbiol. (2012) 152:19–30. doi: 10.1016/j.ijfoodmicro.2011.10.009
38. Beutin L, Miko A, Krause G, Pries K, Haby S, Steege K, et al. Identification of human-pathogenic strains of Shiga toxin-producing Escherichia coli from food by a combination of serotyping and molecular typing of Shiga toxin genes. Appl. Environ. Microbiol. (2007) 73:4769–75. doi: 10.1128/AEM.00873-07
39. Vossenkuhl B, Brandt J, Fetsch A, Käsbohrer A, Kraushaar B, Alt K, et al. Comparison of spa types, SCCmec types and antimicrobial resistance profiles of MRSA isolated from turkeys at farm, slaughter and from retail meat indicates transmission along the production chain. PLoS ONE. (2014) 9:e96308. doi: 10.1371/journal.pone.0096308
40. EFSA. Technical specifications on the harmonised monitoring and reporting of antimicrobial resistance in methicillin-resistant Staphylococcus aureus in food-producing animals and food. EFSA J. (2012) 10:2897. doi: 10.2903/j.efsa.2012.2897
41. EFSA. Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA J. (2011) 9:2322. doi: 10.2903/j.efsa.2011.2322
42. CLSI. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, CLSI Guideline M45. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute (2015).
43. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard-10th ed. CLSI Document M07-A10. Wayne, PA: Clinical and Laboratory Standards Institute (2015).
44. ThermoFisher. Thermo Scientific Sensititre Plate Guide for Antimicrobial Susceptibility Testing. (2018). Available online at: https://assets.thermofisher.com/TFS-Assets/MBD/brochures/Sensititre-Plate-Guide-Booklet-EN.pdf. (accessed January 12, 202).
45. Commission Implementing Decision. 2013/652/EU: Commission Implementing Decision of 12 November 2013 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria (notified under document C(2013) 7145) Text with EEA relevance (2013).
46. Agresti A, Coull BA. Approximate is better than “exact” for interval estimation of binomial proportions. Am. Stat. (1998) 52:119–26. doi: 10.1080/00031305.1998.10480550
47. Roschanski N, Fischer J, Guerra B, Roesler U. Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae. PLoS ONE. (2014) 9:e100956. doi: 10.1371/journal.pone.0100956
48. WHO. Critically Important Antimicrobials for Human Medicine. 6th Revision. Jeneva: World Health Organisation (2019). p. 45.
49. Radhouani H, Silva N, Poeta P, Torres C, Correia S, Igrejas G. Potential impact of antimicrobial resistance in wildlife, environment and human health. Front. Microbiol. (2014) 5:23. doi: 10.3389/fmicb.2014.00023
50. Swift BMC, Bennett M, Waller K, Dodd C, Murray A, Gomes RL, et al. Anthropogenic environmental drivers of antimicrobial resistance in wildlife. Sci. Total Environ. (2019) 649:12–20. doi: 10.1016/j.scitotenv.2018.08.180
51. Van Breda LK, Ward MP. Evidence of antimicrobial and disinfectant resistance in a remote, isolated wild pig population. Prev. Vet. Med. (2017) 147:209–12. doi: 10.1016/j.prevetmed.2017.09.014
52. Dias D, Torres RT, Kronvall G, Fonseca C, Mendo S, Caetano T. Assessment of antibiotic resistance of Escherichia coli isolates and screening of Salmonella spp. in wild ungulates from Portugal. Res. Microbiol. (2015) 166:584–93. doi: 10.1016/j.resmic.2015.03.006
53. Stella S, Tirloni E, Castelli E, Colombo F, Bernardi C. Microbiological evaluation of carcasses of wild boar hunted in a hill area of northern Italy. J. Food Prot. (2018) 81:1519–25. doi: 10.4315/0362-028X.JFP-18-077
54. Bonardi S, Bolzoni L, Zanoni RG, Morganti M, Corradi M, Gilioli S, et al. Limited exchange of Salmonella among domestic pigs and wild boars in italy. EcoHealth. (2019) 16:420–8. doi: 10.1007/s10393-019-01418-2
55. Gil Molino M, García Sánchez A, Risco Pérez D, Gonçalves Blanco P, Quesada Molina A, Rey Pérez J, et al. Prevalence of Salmonella spp. in tonsils, mandibular lymph nodes and faeces of wild boar from Spain and genetic relationship between isolates. Transbound. Emerg. Dis. (2019) 66:1218–26. doi: 10.1111/tbed.13140
56. Navarro-Gonzalez N, Mentaberre G, Porrero CM, Serrano E, Mateos A, López-Martín JM, et al. Effect of cattle on Salmonella carriage, diversity and antimicrobial resistance in free-ranging wild boar (Sus scrofa) in northeastern Spain. PLoS ONE. (2012) 7:e51614. doi: 10.1371/journal.pone.0051614
57. Chiari M, Zanoni M, Tagliabue S, Lavazza A, Alborali LG. Salmonella serotypes in wild boars (Sus scrofa) hunted in northern Italy. Acta Vet. Scand. (2013) 55:42. doi: 10.1186/1751-0147-55-42
58. Holländer R. Die aerobe bakterielle darmflora verschiedener überwinternder Gänsearten. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie. (1982) 252:394–400. doi: 10.1016/S0174-3031(82)80014-0
59. Feare CJ, Sanders MF, Blasco R, Bishop JD. Canada goose (Branta canadensis) droppings as a potential source of pathogenic bacteria. J. R. Soc. Promot. Health. (1999) 119:146–55. doi: 10.1177/146642409911900303
60. Refsum T, Handeland K, Baggesen DL, Holstad G, Kapperud G. Salmonellae in avian wildlife in Norway from 1969 to 2000. Appl. Environ. Microbiol. (2002) 68:5595–9. doi: 10.1128/AEM.68.11.5595-5599.2002
61. Refsum T, Holstad G, Kapperud G, Handeland K. An investigation of Salmonella bacteria in waterfowls and migratory birds in Norway. Acta Vet. Scand. (2005) 46:95–100.
62. Wahlström H, Tysén E, Olsson Engvall E, Brändström B, Eriksson E, Mörner T, et al. Survey of Campylobacter species, VTEC O157 and Salmonella species in Swedish wildlife. Vet. Rec. (2003) 153:74–80. doi: 10.1136/vr.153.3.74
63. Kemper N, Aschfalk A, Höller C. Campylobacter spp., Enterococcus spp., Escherichia coli, Salmonella spp., Yersinia spp., and Cryptosporidium oocysts in semi-domesticated reindeer (Rangifer tarandus tarandus) in Northern Finland and Norway. Acta Vet. Scand. (2006) 48:7. doi: 10.1186/1751-0147-48-7
64. Díaz-Sánchez S, Sánchez S, Herrera-León S, Porrero C, Blanco J, Dahbi G, et al. Prevalence of Shiga toxin-producing Escherichia coli, Salmonella spp. and Campylobacter spp in large game animals intended for consumption: relationship with management practices and livestock influence. Vet. Microbiol. (2013) 163:274–81. doi: 10.1016/j.vetmic.2012.12.026
65. Carbonero A, Paniagua J, Torralbo A, Arenas-Montes A, Borge C, García-Bocanegra I. Campylobacter infection in wild artiodactyl species from southern Spain: occurrence, risk factors and antimicrobial susceptibility. Comp. Immunol. Microbiol. Infect. Dis. (2014) 37:115–21. doi: 10.1016/j.cimid.2014.01.001
66. Colles FM, Ali JS, Sheppard SK, McCarthy ND, Maiden MC. Campylobacter populations in wild and domesticated Mallard ducks (Anas platyrhynchos). Environ. Microbiol. Rep. (2011) 3:574–80. doi: 10.1111/j.1758-2229.2011.00265.x
67. Jamali H, Ghaderpour A, Radmehr B, Chuan Wei KS, Chai LC, Ismail S. Prevalence and antimicrobial resistance of Campylobacter species isolates in ducks and geese. Food Control. (2015) 50:328–30. doi: 10.1016/j.foodcont.2014.09.016
68. Sánchez S, Martínez R, García A, Vidal D, Blanco J, Blanco M, et al. Detection and characterisation of O157:H7 and non-O157 Shiga toxin-producing Escherichia coli in wild boars. Vet. Microbiol. (2010) 143:420–3. doi: 10.1016/j.vetmic.2009.11.016
69. Mora A, López C, Dhabi G, López-Beceiro AM, Fidalgo LE, Díaz EA, et al. Seropathotypes, phylogroups, stx subtypes, and intimin types of wildlife-carried, shiga toxin-producing Escherichia coli strains with the same characteristics as human-pathogenic isolates. Appl. Environ. Microbiol. (2012) 78:2578–85. doi: 10.1128/AEM.07520-11
70. Eggert M, Stüber E, Heurich M, Fredriksson-Ahomaa M, Burgos Y, Beutin L, et al. Detection and characterization of Shiga toxin-producing Escherichia coli in faeces and lymphatic tissue of free-ranging deer. Epidemiol. Infect. (2013) 141:251–9. doi: 10.1017/S0950268812000246
71. Alonso CA, Mora A, Díaz D, Blanco M, González-Barrio D, Ruiz-Fons F, et al. Occurrence and characterization of stx and/or eae-positive Escherichia coli isolated from wildlife, including a typical EPEC strain from a wild boar. Vet. Microbiol. (2017) 207:69–73. doi: 10.1016/j.vetmic.2017.05.028
72. Dias D, Caetano T, Torres RT, Fonseca C, Mendo S. Shiga toxin-producing Escherichia coli in wild ungulates. Sci. Total Environ. (2019) 651:203–9. doi: 10.1016/j.scitotenv.2018.09.162
73. Hofer E, Cernela N, Stephan R. Shiga toxin subtypes associated with Shiga toxin–producing Escherichia coli strains isolated from red deer, roe deer, chamois, and ibex. Foodborne Pathog. Dis. (2012) 9:792–5. doi: 10.1089/fpd.2012.1156
74. Navarro-Gonzalez N, Porrero MC, Mentaberre G, Serrano E, Mateos A, Cabal A, et al. Escherichia coli O157:H7 in wild boars (Sus scrofa) and Iberian ibex (Capra pyrenaica) sharing pastures with free-ranging livestock in a natural environment in Spain. Vet. Q. (2015) 35:102–6. doi: 10.1080/01652176.2015.1023404
75. Szczerba-Turek A, Siemionek J, Socha P, Bancerz-Kisiel A, Platt-Samoraj A, Lipczynska-Ilczuk K, et al. Shiga toxin-producing Escherichia coli isolates from red deer (Cervus elaphus), roe deer (Capreolus capreolus) and fallow deer (Dama dama) in Poland. Food Microbiol. (2020) 86:103352. doi: 10.1016/j.fm.2019.103352
76. Miko A, Pries K, Haby S, Steege K, Albrecht N, Krause G, et al. Assessment of shiga toxin-producing Escherichia coli isolates from wildlife meat as potential pathogens for humans. Appl. Environ. Microbiol. (2009) 75:6462–70. doi: 10.1128/AEM.00904-09
77. Martin A, Beutin L. Characteristics of Shiga toxin-producing Escherichia coli from meat and milk products of different origins and association with food producing animals as main contamination sources. Int. J. Food Microbiol. (2011) 146:99–104. doi: 10.1016/j.ijfoodmicro.2011.01.041
78. Koochakzadeh A, Askari Badouei M, Zahraei Salehi T, Aghasharif S, Soltani M, Ehsan M. Prevalence of Shiga toxin-producing and enteropathogenic Escherichia coli in wild and pet birds in Iran. Braz. J. Poultry Sci. (2015) 17:445–50. doi: 10.1590/1516-635X1704445-450
79. Borges CA, Cardozo MV, Beraldo LG, Oliveira ES, Maluta RP, Barboza KB, et al. Wild birds and urban pigeons as reservoirs for diarrheagenic Escherichia coli with zoonotic potential. J. Microbiol. (2017) 55:344–8. doi: 10.1007/s12275-017-6523-3
80. Literak I, Dolejska M, Radimersky T, Klimes J, Friedman M, Aarestrup FM, et al. Antimicrobial-resistant faecal Escherichia coli in wild mammals in central Europe: multiresistant Escherichia coli producing extended-spectrum beta-lactamases in wild boars. J. Appl. Microbiol. (2010) 108:1702–11. doi: 10.1111/j.1365-2672.2009.04572.x
81. Velhner M, Todorović D, Grego E, Jovčić B, Prunić B, Stojanov I, et al. Fluoroquinolone-resistant and extended-spectrum beta-lactamase producing Escherichia coli isolates from free-living wild animals. Vet. Microbiol. (2018) 223:168–72. doi: 10.1016/j.vetmic.2018.08.011
82. Kullas H, Coles M, Rhyan J, Clark L. Prevalence of Escherichia coli serogroups and human virulence factors in faeces of urban Canada geese (Branta canadensis). Int. J. Environ. Health Res. (2002) 12:153–62. doi: 10.1080/09603120220129319
83. Navarro-Gonzalez N, Porrero MC, Mentaberre G, Serrano E, Mateos A, Domínguez L, et al. Antimicrobial resistance in indicator Escherichia coli isolates from free-ranging livestock and sympatric wild ungulates in a natural environment (Northeastern Spain). Appl. Environ. Microbiol. (2013) 79:6184–6. doi: 10.1128/AEM.01745-13
84. Alonso CA, González-Barrio D, Tenorio C, Ruiz-Fons F, Torres C. Antimicrobial resistance in faecal Escherichia coli isolates from farmed red deer and wild small mammals. Detection of a multiresistant E. coli producing extended-spectrum beta-lactamase. Comp. Immunol. Microbiol. Infect. Dis. (2016) 45:34–9. doi: 10.1016/j.cimid.2016.02.003
85. Alonso CA, González-Barrio D, Ruiz-Fons F, Ruiz-Ripa L, Torres C. High frequency of B2 phylogroup among non-clonally related fecal Escherichia coli isolates from wild boars, including the lineage ST131. FEMS Microbiol. Ecol. (2017) 93:fix016. doi: 10.1093/femsec/fix016
86. Cole D, Drum DJV, Stalknecht DE, White DG, Lee MD, Ayers S, et al. Free-living Canada geese and antimicrobial resistance. Emerg. Infect. Dis. (2005) 11:935–8. doi: 10.3201/eid1106.040717
87. Liakopoulos A, Mevius DJ, Olsen B, Bonnedahl J. The colistin resistance mcr-1 gene is going wild. J. Antimicrob. Chemother. (2016) 71:2335–6. doi: 10.1093/jac/dkw262
88. Ahmed ZS, Elshafiee EA, Khalefa HS, Kadry M, Hamza DA. Evidence of colistin resistance genes (mcr-1 and mcr-2) in wild birds and its public health implication in Egypt. Antimicrob. Resist. Infect. Control. (2019) 8:197. doi: 10.1186/s13756-019-0657-5
89. Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, Lehner-Reindl V, et al. Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob. Agents Chemother. (2014) 58:1228–30. doi: 10.1128/AAC.01993-13
90. Hasan B, Sandegren L, Melhus A, Drobni M, Hernandez J, Waldenström J, et al. Antimicrobial drug-resistant Escherichia coli in wild birds and free-range poultry, Bangladesh. Emerg. Infect. Dis. (2012) 18:2055–8. doi: 10.3201/eid1812.120513
91. Veldman K, Tulden PV, Kant A, Testerink J, Mevius D. Characteristics of cefotaxime-resistant Escherichia coli from wild birds in The Netherlands. Appl. Environ. Microbiol. (2013) 79:7556–61. doi: 10.1128/AEM.01880-13
92. Alcalá L, Alonso CA, Simón C, González-Esteban C, Orós J, Rezusta A. Wild birds, frequent carriers of Extended-Spectrum β-lactamase (ESBL) producing Escherichia coli of CTX-M and SHV-12 types. Microb. Ecol. (2016) 72:861–9. doi: 10.1007/s00248-015-0718-0
93. Ben Yahia H, Ben Sallem R, Tayh G, Klibi N, Ben Amor I, Gharsa H, et al. Detection of CTX-M-15 harboring Escherichia coli isolated from wild birds in Tunisia. BMC Microbiol. (2018) 18:26. doi: 10.1186/s12866-018-1163-2
94. Bonardi S, Cabassi CS, Longhi S, Pia F, Corradi M, Gilioli S, et al. Detection of extended- spectrum beta-lactamase producing Escherichia coli from mesenteric lymph nodes of wild boars (Sus scrofa). Ital. J. Food Saf. (2018) 7:7707. doi: 10.4081/ijfs.2018.7707
95. Darwich L, Vidal A, Seminati C, Albamonte A, Casado A, López F, et al. High prevalence and diversity of extended-spectrum β-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia. PLoS ONE. (2019) 14:e0210686. doi: 10.1371/journal.pone.0210686
96. Poeta P, Radhouani H, Pinto L, Martinho A, Rego V, Rodrigues R, et al. Wild boars as reservoirs of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli of different phylogenetic groups. J. Basic Microbiol. (2009) 49:584–8. doi: 10.1002/jobm.200900066
97. Madec JY, Haenni M, Nordmann P, Poirel L. Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? Clin. Microbiol. Infec. (2017) 23:826–33. doi: 10.1016/j.cmi.2017.01.013
98. Kaesbohrer A, Bakran-Lebl K, Irrgang A, Fischer J, Kämpf P, Schiffmann A, et al. Diversity in prevalence and characteristics of ESBL/pAmpC producing E. coli in food in Germany. Vet. Microbiol. (2019) 233:52–60. doi: 10.1016/j.vetmic.2019.03.025
99. Pietsch M, Eller C, Wendt C, Holfelder M, Falgenhauer L, Fruth A, et al. Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany. Vet. Microbiol. (2017) 200:130–7. doi: 10.1016/j.vetmic.2015.11.028
100. Pfeifer Y, Eller C, Leistner R, Valenza G, Nickel S, Guerra B, et al. ESBL-Bildner als Infektionserreger beim Menschen und die Frage nach dem zoonotischen Reservoir. Robert Koch-Institut, Infektionskrankheiten/Erreger.
101. Ceccarelli D, Kant A, van Essen-Zandbergen A, Dierikx C, Hordijk J, Wit B, et al. Diversity of plasmids and genes encoding resistance to extended spectrum cephalosporins in commensal Escherichia coli from Dutch livestock in 2007-2017. Front. Microbiol. (2019) 10:76. doi: 10.3389/fmicb.2019.00076
102. Kraushaar B, Fetsch A. First description of PVL-positive methicillin-resistant Staphylococcus aureus (MRSA) in wild boar meat. Int. J. Food Microbiol. (2014) 186:68–73. doi: 10.1016/j.ijfoodmicro.2014.06.018
103. McDougal LK, Thornsberry C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J. Clin. Microbiol. (1986) 23:832–9. doi: 10.1128/JCM.23.5.832-839.1986
104. Meemken D, Blaha T. Research on the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) in domestic pigs and wild boars in Germany. Dtsch Tierarztl. Wochenschr. (2009) 116:297–301. doi: 10.31274/safepork-180809-891
105. Cuny C, Friedrich AW, Witte W. Absence of livestock-associated methicillin-resistant Staphylococcus aureus clonal complex CC398 as a nasal colonizer of pigs raised in an alternative system. Appl. Environ. Microbiol. (2012) 78:1296–7. doi: 10.1128/AEM.07260-11
106. Meemken D, Blaha T, Hotzel H, Strommenger B, Klein G, Ehricht R, et al. Genotypic and phenotypic characterization of Staphylococcus aureus isolates from wild boars. Appl. Environ. Microbiol. (2013) 79:1739–42. doi: 10.1128/AEM.03189-12
107. Meyer C, Heurich M, Huber I, Krause G, Ullrich U, Fetsch A. The importance of wildlife as reservoir of antibiotic-resistant bacteria in Bavaria–first results. Berl. Munch Tierarztl. Wochenschr. (2014) 127:129–34. doi: 10.2376/0005-9366-127-129
108. Seinige D, Von Altrock A, Kehrenberg C. Genetic diversity and antibiotic susceptibility of Staphylococcus aureus isolates from wild boars. Comp. Immunol. Microbiol. Infect. Dis. (2017) 54:7–12. doi: 10.1016/j.cimid.2017.07.003
109. Mama OM, Ruiz-Ripa L, Fernández-Fernández R, González-Barrio D, Ruiz-Fons JF, Torres C. High frequency of coagulase-positive staphylococci carriage in healthy wild boar with detection of MRSA of lineage ST398-t011. FEMS Microbiol. Lett. (2019) 366:fny292. doi: 10.1093/femsle/fny292
110. Guerrero-Ramos E, Cordero J, Molina-González D, Poeta P, Igrejas G, Alonso-Calleja C, et al. Antimicrobial resistance and virulence genes in enterococci from wild game meat in Spain. Food Microbiol. (2016) 53:156–64. doi: 10.1016/j.fm.2015.09.007
111. Bandick N, Hensel A. Zoonotic diseases and direct marketing of game meat: aspects of consumer safety in Germany. In: Paulsen P, Bauer A, Vodnansky M, Winkelmayer R, Smulders FJM, editors. Game Meat Hygiene in Focus: Microbiology, Epidemiology, Risk Analysis and Quality Assurance. Wageningen: Wageningen Academic Publishers (2011). p. 93–100. doi: 10.3920/978-90-8686-723-3_4
112. Obwegeser T, Stephan R, Hofer E, Zweifel C. Shedding of foodborne pathogens and microbial carcass contamination of hunted wild ruminants. Vet. Microbiol. (2012) 159:149–54. doi: 10.1016/j.vetmic.2012.03.031
113. Plaza-Rodríguez C, Kaesbohrer A, Tenhagen B-A. Probabilistic model for the estimation of the consumer exposure to methicillin-resistant Staphylococcus aureus due to cross-contamination and recontamination. MicrobiologyOpen. (2019) 8:e900. doi: 10.1002/mbo3.900
114. Rüegg SR, McMahon BJ, Häsler B, Esposito R, Nielsen LR, Ifejika Speranza C, et al. A blueprint to evaluate one health. Front. Public Health. (2017) 5:20. doi: 10.3389/fpubh.2017.00020
115. Mesa Varona O, Chaintarli K, Muller-Pebody B, Anjum MF, Eckmanns T, Norström M, et al. Monitoring antimicrobial resistance and drug usage in the human and livestock sector and foodborne antimicrobial resistance in six European countries. Infect. Drug Resist. (2020) 13:957–93. doi: 10.2147/IDR.S237038
Keywords: monitoring, one health, zoonotic agents, antimicrobial resistance (AMR), wild boar, cervids, wild bird, Germany
Citation: Plaza-Rodríguez C, Alt K, Grobbel M, Hammerl JA, Irrgang A, Szabo I, Stingl K, Schuh E, Wiehle L, Pfefferkorn B, Naumann S, Kaesbohrer A and Tenhagen B-A (2021) Wildlife as Sentinels of Antimicrobial Resistance in Germany? Front. Vet. Sci. 7:627821. doi: 10.3389/fvets.2020.627821
Received: 10 November 2020; Accepted: 31 December 2020;
Published: 27 January 2021.
Edited by:
Ana De La Torre, Instituto Nacional de Investigación y Tecnología Agroalimentaria (INIA), SpainReviewed by:
Jorge Blanco, University of Santiago de Compostela, SpainCarlos Sacristán Yagüe, University of São Paulo, Brazil
Copyright © 2021 Plaza-Rodríguez, Alt, Grobbel, Hammerl, Irrgang, Szabo, Stingl, Schuh, Wiehle, Pfefferkorn, Naumann, Kaesbohrer and Tenhagen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carolina Plaza-Rodríguez, Carolina.Plaza-Rodriguez@bfr.bund.de